Openly accessible

Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression

Germinario, Ralph J., Colby-Germinario, S. P., Acel, A., Chandok, R., Davison, K., Mak, J., Kleiman, L., Faust, E. and Wainberg, M. A. 1999, Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression, AIDS research and human retroviruses, vol. 15, no. 9, pp. 829-836.

Attached Files
Name Description MIMEType Size Downloads
mak-effectofinsulin-1999.pdf Published version application/pdf 435.53KB 4

Title Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression
Author(s) Germinario, Ralph J.
Colby-Germinario, S. P.
Acel, A.
Chandok, R.
Davison, K.
Mak, J.
Kleiman, L.
Faust, E.
Wainberg, M. A.
Journal name AIDS research and human retroviruses
Volume number 15
Issue number 9
Start page 829
End page 836
Total pages 9
Publisher Mary Ann Liebert
Place of publication New Rochelle, N. Y.
Publication date 1999-07-05
ISSN 0889-2229
1931-8405
Keyword(s) insulin-growth factor I
HIV
cell
Summary In this study, we have investigated the ability of insulin-like growth factor I (IGF-I) to inhibit HIV long terminal repeat (LTR)-driven gene expression. Using COS 7 cells cotransfected with tat and an HIV LTR linked to a chloramphenicol acetyltransferase (CAT) reporter, we observed that physiological levels of IGF-I (10-9 M) significantly inhibited CAT expression in a concentration- and time-dependent manner. IGF-I did not inhibit C AT expression in COS 7 cells transfected with pSVCAT, and did not affect CAT expression in the absence of cotransfection with tat . Transfection of HIV-1 proviral DNA into COS 7 cells +/- IGF-I resulted in a significant decrease ( p 0.05) in infectious virion production. Both IGF-I and Ro24-7429 inhibited LTR-driven C AT expression, while TNF- alpha -enhanced CAT expression was not affected by IGF-I. On the other hand, a plasmid encoding parathyroid hormone-related peptide exhibited dramatic additivity of inhibition of CAT expression in COS 7 cells. Finally, we show that in Jurkat or U937 cells cotransfected with HIVLTRCAT/tat, IGF-I significantly inhibited CAT expression. Further, interleukin 4 showed in U937 cells inhibition of CAT expression that was not additive to IGF-I induced inhibition. Our data demonstrate that IGF-I can specifically inhibit HIVLTRCAT expression. This inhibition may occur at the level of the tat /TAR interaction. Finally, this IGF-I effect is seen in target cell lines and similar paths of inhibition may be involved in the various cell types employed.
Language eng
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©1999, Mary Ann Liebert
Persistent URL http://hdl.handle.net/10536/DRO/DU:30047426

Document type: Journal Article
Collections: School of Medicine
Open Access Collection
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in TR Web of Science
Google Scholar Search Google Scholar
Access Statistics: 21 Abstract Views, 5 File Downloads  -  Detailed Statistics
Created: Thu, 30 Aug 2012, 09:28:30 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.